Literature DB >> 10406769

Chlamydia screening can have high take-up rates if right methodology is used.

J Macleod, G D Smith.   

Abstract

Mesh：

Year:  1999        PMID： 10406769      PMCID： PMC1116283          DOI： 10.1136/bmj.319.7203.188b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Sexuality and health: the hidden costs of screening for Chlamydia trachomatis.

Authors:  B Duncan; G Hart
Journal:  BMJ       Date:  1999-04-03

2.  Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey.

Authors:  L Grun; J Tassano-Smith; C Carder; A M Johnson; A Robinson; E Murray; J Stephenson; A Haines; A Copas; G Ridgway
Journal:  BMJ       Date:  1997-07-26

3.  Screening for chlamydia to prevent pelvic inflammatory disease.

Authors:  E I Abter; M A Mahmud
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

4.  Postal urine specimens: are they a feasible method for genital chlamydial infection screening?

Authors:  J Macleod; R Rowsell; P Horner; T Crowley; E O Caul; N Low; G D Smith
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386
  4 in total
  2 in total

1.  Evidence based health policy report. Screening for genital chlamydial infection.

Authors:  J Pimenta; M Catchpole; M Gray; J Hopwood; S Randall
Journal:  BMJ       Date:  2000-09-09

2.  Prevalence of asymptomatic urethritis by Chlamydia trachomatis and Neisseria gonorrhoeae and associated risk factors among males living with HIV-1.

Authors:  Guilherme Almeida Rosa da Silva; Heloisa Loureiro de Sá Neves Motta; Erik Friedrich Alex de Souza; Pedro Afonso Nogueira Moises Cardoso; José Henrique Pilotto; Walter Araujo Eyer-Silva; Luiz Cláudio Pereira Ribeiro; Mônica Soares Dos Santos; Marcelo Costa Velho Mendes de Azevedo; Jorge Francisco da Cunha Pinto; Rogerio Neves Motta; Fernando Raphael de Almeida Ferry
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-03-08       Impact factor: 1.846
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.